Pathways altered in the intestinal type gastric cancer include alterations in p53 signaling pathway, Wnt/β-Catenin signaling pathway, PI3K/AKT signaling pathway, and TGFβ signaling pathway [32]. This evidence concerns the gene TP53 and gastric cancer.